To generate a bank of well-characterized biological samples from human subjects prior to or following organ transplantation for the purpose of subsequent evaluation using new and existing immunological assays

To validate the predictive accuracy and ROC characteristics of the percentage of circulating cell-free donor-derived DNA (%ccfdDNA) in a multicenter, prospective cohort study of heart-and lung-transplant patients, recruited through a consortium ...

Percentage of patients assigned to Arm latent membrane protein-specific T-cells (LMP-TC) with successful LMP-specific T cell product match, were treated within two weeks of the expected start date, and received both weekly doses

Percentage of patients successfully matched to a latent membrane protein (LMP)-specific T cell product derived from a third party LMP-specific T cell bank

Progression-free survival (PFS)

(and 6 more...)

90

All

up to 29 Years (Child, Adult)

NCT02900976

ANHL1522NCI-2016-01110U10CA180886

March 6, 2017

December 31, 2021

December 31, 2021

September 15, 2016

August 7, 2018

Children's Hospital of AlabamaBirmingham, Alabama, United States

Phoenix Childrens HospitalPhoenix, Arizona, United States

Loma Linda University Medical CenterLoma Linda, California, United States